Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for CNS complications in cardiac surgery
NCT06551259Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in anxiety disorder, postoperative depression, postoperative delirium (POD), sponsored by Chinese PLA General Hospital. Started Jan 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorderpostoperative depressionpostoperative delirium (POD)
Beyond the preview
Go deeper on NCT06551259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06551259.